Buy Rating Affirmed for NRX Pharmaceuticals Amid Promising Outlook for Novel Depression Treatment NRX-100
TipRanksJan 22 14:09 ET
Analysts Are Bullish on These Healthcare Stocks: HCA Healthcare (HCA), NRX Pharmaceuticals (NRXP)
TipRanksOct 24, 2023 09:50 ET
H.C. Wainwright Sticks to Their Buy Rating for NRX Pharmaceuticals (NRXP)
TipRanksMay 25, 2023 06:15 ET
HC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $2 Price Target
BenzingaMay 25, 2023 06:07 ET
Ascendiant Remains a Buy on NRX Pharmaceuticals (NRXP)
TipRanksApr 7, 2023 04:20 ET
H.C. Wainwright Sticks to Their Buy Rating for NRX Pharmaceuticals (NRXP)
TipRanksFeb 2, 2023 12:20 ET
NRX Pharmaceuticals Analyst Ratings
Benzinga Analyst RatingsFeb 2, 2023 12:18 ET
HC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $2 Price Target
Benzinga Real-time NewsFeb 2, 2023 12:18 ET
H.C. Wainwright Remains a Buy on NRX Pharmaceuticals (NRXP)
TipRanksJan 19, 2023 09:20 ET
Analysts Offer Insights on Healthcare Companies: NRX Pharmaceuticals (NRXP) and Arcutis Biotherapeutics (ARQT)
TipRanksNov 15, 2022 09:58 ET
NRX Pharmaceuticals Analyst Ratings
Benzinga Analyst RatingsNov 9, 2022 06:22 ET
Ascendiant Capital Initiates Coverage On NRX Pharmaceuticals With Buy Rating, Announces Price Target of $4
Benzinga Real-time NewsNov 9, 2022 06:22 ET
H.C. Wainwright Sticks to Their Buy Rating for NRX Pharmaceuticals (NRXP)
TipRanksSep 8, 2022 10:40 ET
HC Wainwright Starts NRX Pharmaceuticals at Buy With $2 Price Target
MT NewswiresJun 30, 2022 22:08 ET
NRX Pharmaceuticals Price Target Announced at $2.00/Share by HC Wainwright & Co.
Dow JonesJun 30, 2022 06:30 ET
NRX Pharmaceuticals Initiated at Buy by HC Wainwright & Co.
Dow JonesJun 30, 2022 06:30 ET
Analysts Offer Insights on Healthcare Companies: Aileron Therapeutics (ALRN), NRX Pharmaceuticals (NRXP) and Cybin (CYBN)
TipRanksJun 30, 2022 06:21 ET
NRX Pharmaceuticals analyst ratings
Benzinga Analyst RatingsJun 30, 2022 06:20 ET
No Data
No Data